IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ -- Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced its full year and Q4 2024 financial results. Søren Tulstrup, President and CEO, Hansa Biopharma...
Read More Details
Finally We wish PressBee provided you with enough information of ( Hansa Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results )
Also on site :
- Russell Crowe, 61, Debuts a Svelte and Dapper Look at Wimbledon
- Dozens dead in pharmaceutical factory blast in southern India
- Elon Musk says Trump’s ‘Big Beautiful Bill’ could spell disaster for America. Here are its biggest pain points, according to critics